[1]
2014. Obligations, precautions and pending issues in regulatory development for radiopharmaceuticals in Brazil . Brazilian Journal of Pharmaceutical Sciences. 50, 2 (Apr. 2014), 285–290. DOI:https://doi.org/10.1590/S1984-82502014000200007.